|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-1-29
|
|
pubmed:abstractText |
We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous infusion fluorouracil (5-FU) (ECF regimen) with the standard combination of 5-FU, doxorubicin, and methotrexate (FAMTX) in previously untreated patients with advanced esophagogastric cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:CunninghamDD,
pubmed-author:FindlayMM,
pubmed-author:HarperPP,
pubmed-author:HickishTT,
pubmed-author:HillAA,
pubmed-author:HughesMM,
pubmed-author:IvesonTT,
pubmed-author:JoffeJ KJK,
pubmed-author:MansiJJ,
pubmed-author:MeehanMM,
pubmed-author:NicolsonMM,
pubmed-author:NormanAA,
pubmed-author:O'BrienMM,
pubmed-author:OatesJJ,
pubmed-author:ScarffeJ HJH,
pubmed-author:UnderhillCC,
pubmed-author:WardleyAA,
pubmed-author:WatsonMM,
pubmed-author:WebbAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-7
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8996151-Adenocarcinoma,
pubmed-meshheading:8996151-Adult,
pubmed-meshheading:8996151-Aged,
pubmed-meshheading:8996151-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8996151-Carcinoma,
pubmed-meshheading:8996151-Cisplatin,
pubmed-meshheading:8996151-Costs and Cost Analysis,
pubmed-meshheading:8996151-Doxorubicin,
pubmed-meshheading:8996151-Drug Costs,
pubmed-meshheading:8996151-Epirubicin,
pubmed-meshheading:8996151-Esophageal Neoplasms,
pubmed-meshheading:8996151-Female,
pubmed-meshheading:8996151-Fluorouracil,
pubmed-meshheading:8996151-Humans,
pubmed-meshheading:8996151-Male,
pubmed-meshheading:8996151-Methotrexate,
pubmed-meshheading:8996151-Middle Aged,
pubmed-meshheading:8996151-Prospective Studies,
pubmed-meshheading:8996151-Quality of Life,
pubmed-meshheading:8996151-Stomach Neoplasms,
pubmed-meshheading:8996151-Survival Rate
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
|
|
pubmed:affiliation |
Cancer Research Campaign (CRC) Section of Medicine, Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
